Clinical trial
Pilot Therapeutic Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia
NCT05992077 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Therapeutic Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 7, 2023
- Completion date
- January 31, 2026
- Enrollment
- 21,000 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hcv infection